High Cbd Thc Ratio
The High CBD:THC Ratio family encompasses cannabis strains where cannabidiol (CBD) comprises a substantial proportion relative to tetrahydrocannabinol (THC). Lineage records frequently report ratios ranging from 1:1 to 20:1 (CBD:THC) or higher, with notable parent lines including Charlotte's Web, Cannatonic, and Harlequin. Breeders working in this category often stabilize these ratios through selective backcrossing to CBD-dominant or balanced parents. This classification reflects biochemical phenotype rather than a single genetic origin, as CBD-dominant traits appear across diverse geographic and breeding populations. Understanding ratio stability across generations remains essential for consistent seed development and cultivation planning.
High Cbd Thc Ratio strains
No strains tagged into High Cbd Thc Ratio yet — they'll appear here as breeders submit lineage records under this family.
The High CBD:THC Ratio family encompasses cannabis strains where cannabidiol (CBD) comprises a substantial proportion relative to tetrahydrocannabinol (THC). Lineage records frequently report ratios ranging from 1:1 to 20:1 (CBD:THC) or higher, with notable parent lines including Charlotte's Web, Cannatonic, and Harlequin. Breeders working in this category often stabilize these ratios through selective backcrossing to CBD-dominant or balanced parents. This classification reflects biochemical phenotype rather than a single genetic origin, as CBD-dominant traits appear across diverse geographic and breeding populations. Understanding ratio stability across generations remains essential for consistent seed development and cultivation planning.
Breeders leverage high CBD:THC ratio strains as parent material to introduce or enhance CBD expression in offspring while managing THC levels for regulatory compliance or market positioning. Establishing stable ratios requires multi-generation selection and standardized cannabinoid testing to verify consistency before seed release.
Educational reference · Cultivar metadata only · No medical claims